Literature DB >> 6314975

Effect of serial embryo passage of an Arkansas-type avian infectious bronchitis virus isolate on clinical response, virus recovery, and immunity.

J Gelb, S S Cloud.   

Abstract

Infectious bronchitis virus (IBV) Arkansas-type DPI strain (Ark DPI) was attenuated by serial passage in chicken embryos. Virus of passage 50 was less pathogenic for day-old maternally immune broiler-type chickens than virus of passage 10 or 25 as determined by clinical response to vaccination, virus isolation in respiratory (trachea) and nonrespiratory (kidney and cloaca) tissues, and weight-gain studies. Chickens vaccinated with virus of passage 10, 25, or 50 were at least 80% resistant to homologous virus challenge of the upper respiratory tract 4 and 6 weeks postvaccination. Serum antibody production by passage-50-vaccinated chickens was comparatively low at 4 weeks but at 6 weeks was similar to that in chickens vaccinated with virus of passage 10 or 25.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314975

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  11 in total

1.  Safety and efficacy of an attenuated Chinese QX-like infectious bronchitis virus strain as a candidate vaccine.

Authors:  Ye Zhao; Jin-long Cheng; Xiao-yu Liu; Jing Zhao; Yan-xin Hu; Guo-zhong Zhang
Journal:  Vet Microbiol       Date:  2015-08-05       Impact factor: 3.293

2.  The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity--a preliminary study.

Authors:  Kylie A Hewson; Peter C Scott; Joanne M Devlin; Jagoda Ignjatovic; Amir H Noormohammadi
Journal:  Vaccine       Date:  2012-04-26       Impact factor: 3.641

Review 3.  Infectious bronchitis virus variants: a review of the history, current situation and control measures.

Authors:  J J Sjaak de Wit; Jane K A Cook; Harold M J F van der Heijden
Journal:  Avian Pathol       Date:  2011-06       Impact factor: 3.378

4.  Quantification of infectious bronchitis coronavirus by titration in vitro and in ovo.

Authors:  Joeri Kint; Helena Jane Maier; Erik Jagt
Journal:  Methods Mol Biol       Date:  2015

5.  The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity.

Authors:  Maria Armesto; Dave Cavanagh; Paul Britton
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

6.  Genomic characteristics and changes of avian infectious bronchitis virus strain CK/CH/LDL/97I after serial passages in chicken embryos.

Authors:  Fei Zhao; Zongxi Han; Tingting Zhang; Yuhao Shao; Xiangang Kong; Huijie Ma; Shengwang Liu
Journal:  Intervirology       Date:  2014-08-29       Impact factor: 1.763

7.  Altered pathogenicity, immunogenicity, tissue tropism and 3'-7kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos.

Authors:  Shengwang Liu; Xiaonan Zhang; Liyang Gong; Baolong Yan; Chengren Li; Zongxi Han; Yuhao Shao; Huixin Li; Xiangang Kong
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

8.  Polymorphisms in the S1 spike glycoprotein of Arkansas-type infectious bronchitis virus (IBV) show differential binding to host tissues and altered antigenicity.

Authors:  Christina Leyson; Monique França; Mark Jackwood; Brian Jordan
Journal:  Virology       Date:  2016-09-15       Impact factor: 3.616

9.  Attenuated live infectious bronchitis virus QX vaccine disseminates slowly to target organs distant from the site of inoculation.

Authors:  A Laconi; E A W S Weerts; J C G Bloodgood; J P Deniz Marrero; A J Berends; G Cocciolo; J J de Wit; M H Verheije
Journal:  Vaccine       Date:  2019-12-09       Impact factor: 3.641

10.  Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens.

Authors:  Huixin Li; Yulong Wang; Zongxi Han; Yu Wang; Shulin Liang; Lu Jiang; Yonghao Hu; Xiangang Kong; Shengwang Liu
Journal:  Antiviral Res       Date:  2016-03-02       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.